Morse Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.58M | Sell |
10,287
-174
| -2% | -$77.5K | 1% | 31 |
|
2025
Q1 | $5.07M | Sell |
10,461
-94
| -0.9% | -$45.6K | 1.28% | 26 |
|
2024
Q4 | $4.25M | Buy |
10,555
+578
| +6% | +$233K | 0.97% | 27 |
|
2024
Q3 | $4.64M | Sell |
9,977
-138
| -1% | -$64.2K | 1% | 26 |
|
2024
Q2 | $4.74M | Sell |
10,115
-80
| -0.8% | -$37.5K | 1.15% | 28 |
|
2024
Q1 | $4.26M | Buy |
10,195
+706
| +7% | +$295K | 1.09% | 33 |
|
2023
Q4 | $3.86M | Buy |
9,489
+1,547
| +19% | +$629K | 1.14% | 32 |
|
2023
Q3 | $2.76M | Buy |
7,942
+621
| +8% | +$216K | 0.87% | 39 |
|
2023
Q2 | $2.58M | Buy |
7,321
+1,425
| +24% | +$501K | 0.78% | 42 |
|
2023
Q1 | $1.86M | Buy |
5,896
+681
| +13% | +$215K | 0.63% | 52 |
|
2022
Q4 | $1.51M | Buy |
5,215
+1,278
| +32% | +$369K | 0.55% | 57 |
|
2022
Q3 | $1.14M | Buy |
3,937
+2,105
| +115% | +$610K | 0.43% | 67 |
|
2022
Q2 | $516K | Buy |
1,832
+375
| +26% | +$106K | 0.17% | 109 |
|
2022
Q1 | $380K | Buy |
+1,457
| New | +$380K | 0.09% | 139 |
|
2021
Q1 | – | Sell |
-1,268
| Closed | -$300K | – | 163 |
|
2020
Q4 | $300K | Sell |
1,268
-9,710
| -88% | -$2.3M | 0.08% | 118 |
|
2020
Q3 | $2.99M | Buy |
10,978
+2,411
| +28% | +$656K | 0.96% | 28 |
|
2020
Q2 | $2.49M | Buy |
8,567
+4,837
| +130% | +$1.4M | 0.89% | 33 |
|
2020
Q1 | $888K | Buy |
3,730
+2,419
| +185% | +$576K | 0.42% | 56 |
|
2019
Q4 | $287K | Buy |
+1,311
| New | +$287K | 0.1% | 113 |
|
2019
Q3 | – | Sell |
-9,628
| Closed | -$1.77M | – | 142 |
|
2019
Q2 | $1.77M | Sell |
9,628
-2,880
| -23% | -$528K | 0.52% | 56 |
|
2019
Q1 | $2.3M | Buy |
12,508
+6,795
| +119% | +$1.25M | 0.69% | 45 |
|
2018
Q4 | $947K | Sell |
5,713
-10,102
| -64% | -$1.67M | 0.34% | 70 |
|
2018
Q3 | $3.05M | Buy |
15,815
+9,764
| +161% | +$1.88M | 0.8% | 40 |
|
2018
Q2 | $1.03M | Buy |
6,051
+675
| +13% | +$115K | 0.28% | 83 |
|
2018
Q1 | $876K | Buy |
5,376
+46
| +0.9% | +$7.5K | 0.24% | 86 |
|
2017
Q4 | $799K | Buy |
5,330
+180
| +3% | +$27K | 0.22% | 87 |
|
2017
Q3 | $783K | Buy |
+5,150
| New | +$783K | 0.23% | 86 |
|